Copyright Reports & Markets. All rights reserved.

Global Neurogenetic Testing Market Opportunities and Forecast 2022-2028

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Neurogenetic Testing Market Status and Forecast (2017-2028)
      • 1.3.2 Global Neurogenetic Testing Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Neurogenetic Testing Supply by Company

    • 2.1 Global Neurogenetic Testing Sales Value by Company
    • 2.2 Neurogenetic Testing Sales Area of Main Manufacturers
    • 2.3 Trend of Concentration Rate

    3 Global and Regional Neurogenetic Testing Market Status by Type

    • 3.1 Neurogenetic Testing Type Introduction
      • 3.1.1 MRI
      • 3.1.2 Next Generation Sequencing
      • 3.1.3 Multiplex Ligation-dependent Probe Amplification (MLPA)
      • 3.1.4 Fragment Analysis PCR
    • 3.2 Global Neurogenetic Testing Market by Type
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Neurogenetic Testing Market Status by Application

    • 4.1 Neurogenetic Testing Segment by Application
      • 4.1.1 Hospitals
      • 4.1.2 Specialty Clinics
      • 4.1.3 Research Institutes
      • 4.1.4 Diagnostics Laboratories
    • 4.2 Global Neurogenetic Testing Market by Application
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Neurogenetic Testing Market Status by Region

    • 5.1 Global Neurogenetic Testing Market by Region
    • 5.2 North America Neurogenetic Testing Market Status
    • 5.3 Europe Neurogenetic Testing Market Status
    • 5.4 Asia Pacific Neurogenetic Testing Market Status
    • 5.5 Central & South America Neurogenetic Testing Market Status
    • 5.6 Middle East & Africa Neurogenetic Testing Market Status

    6 North America Neurogenetic Testing Market Status

    • 6.1 North America Neurogenetic Testing Market by Country
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Neurogenetic Testing Market Status

    • 7.1 Europe Neurogenetic Testing Market by Country
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Neurogenetic Testing Market Status

    • 8.1 Asia Pacific Neurogenetic Testing Market by Country
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Neurogenetic Testing Market Status

    • 9.1 Central & South America Neurogenetic Testing Market by Country
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Neurogenetic Testing Market Status

    • 10.1 Middle East & Africa Neurogenetic Testing Market by Country
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Major Downstream Customers Analysis

    • 11.1 Customer One Analysis
    • 11.2 Customer Two Analysis
    • 11.3 Customer Three Analysis
    • 11.4 Customer Four Analysis

    12 Global Neurogenetic Testing Market Forecast by Type and by Application

    • 12.1 Global Neurogenetic Testing Sales Value Forecast (2023-2028)
    • 12.2 Global Neurogenetic Testing Forecast by Type
    • 12.3 Global Neurogenetic Testing Forecast by Application

    13 Global Neurogenetic Testing Market Forecast by Region/Country

    • 13.1 Global Neurogenetic Testing Market Forecast by Region (2023-2028)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 Victorian Clinical Genetics Services
      • 14.1.1 Company Information
      • 14.1.2 Neurogenetic Testing Product Introduction
      • 14.1.3 Victorian Clinical Genetics Services Neurogenetic Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.1.4 SWOT Analysis
    • 14.2 Pacific Biosciences of California
      • 14.2.1 Company Information
      • 14.2.2 Neurogenetic Testing Product Introduction
      • 14.2.3 Pacific Biosciences of California Neurogenetic Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.2.4 SWOT Analysis
    • 14.3 Neurogene
      • 14.3.1 Company Information
      • 14.3.2 Neurogenetic Testing Product Introduction
      • 14.3.3 Neurogene Neurogenetic Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.3.4 SWOT Analysis
    • 14.4 MedGenome Labs
      • 14.4.1 Company Information
      • 14.4.2 Neurogenetic Testing Product Introduction
      • 14.4.3 MedGenome Labs Neurogenetic Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.4.4 SWOT Analysis
    • 14.5 Mayo Clinic
      • 14.5.1 Company Information
      • 14.5.2 Neurogenetic Testing Product Introduction
      • 14.5.3 Mayo Clinic Neurogenetic Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.5.4 SWOT Analysis
    • 14.6 Labcorp
      • 14.6.1 Company Information
      • 14.6.2 Neurogenetic Testing Product Introduction
      • 14.6.3 Labcorp Neurogenetic Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.6.4 SWOT Analysis
    • 14.7 GeneDx
      • 14.7.1 Company Information
      • 14.7.2 Neurogenetic Testing Product Introduction
      • 14.7.3 GeneDx Neurogenetic Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.7.4 SWOT Analysis
    • 14.8 Blueprint Genetics
      • 14.8.1 Company Information
      • 14.8.2 Neurogenetic Testing Product Introduction
      • 14.8.3 Blueprint Genetics Neurogenetic Testing Sales Value, Gross Margin and Global Share (2020-2022)
      • 14.8.4 SWOT Analysis

    15 Conclusion

      16 Methodology

      This report provides a comprehensive analysis of current global Neurogenetic Testing market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario.This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Neurogenetic Testing industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

      According to GRD Survey, the global Neurogenetic Testing market is estimated at $ million in 2021, and projected to grow at a CAGR of % to $ million by 2028.

      Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Neurogenetic Testing Market Opportunities and Forecast 2023-2028 report makes a brilliant attempt to unveil key opportunities available in the global Neurogenetic Testing market under the Covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

      The Global Neurogenetic Testing Market has been exhibited in detail in the following chapters
      Chapter 1 displays the basic product introduction and market overview.
      Chapter 2 provides the competition landscape of global Neurogenetic Testing industry.
      Chapter 3 provides the market analysis by type and by region
      Chapter 4 provides the market analysis by application and by region
      Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
      Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
      Chapter 12 provides the market forecast by type and by application
      Chapter 13 provides the market forecast by region
      Chapter 14 profies global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
      Chapter 15 conclusions

      Segmented by Type
      MRI
      Next Generation Sequencing
      Multiplex Ligation-dependent Probe Amplification (MLPA)
      Fragment Analysis PCR

      Segmented by Application
      Hospitals
      Specialty Clinics
      Research Institutes
      Diagnostics Laboratories

      Segmented by Country
      North America
      United States
      Canada
      Mexico
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Asia Pacific
      China
      Japan
      Korea
      Southeast Asia
      India
      Australasia
      Central & South America
      Brazil
      Argentina
      Colombia
      Middle East & Africa
      Iran
      Israel
      Turkey
      South Africa
      Saudi Arabia

      Key manufacturers included in this survey
      Victorian Clinical Genetics Services
      Pacific Biosciences of California
      Neurogene
      MedGenome Labs
      Mayo Clinic
      Labcorp
      GeneDx
      Blueprint Genetics
      Buy now